Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (7): 444-446.
Previous Articles Next Articles
ZHANG Yanli , CHEN Lu, GUI Yue
Received:2019-08-06
Revised:2019-08-06
Online:2019-07-20
Published:2019-08-06
CLC Number:
ZHANG Yanli , CHEN Lu, GUI Yue. One Case of Dysuria Induced by Chinese Medicine Dispensing Granules Containing Ephedra[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 444-446.
Add to citation manager EndNote|Ris|BibTeX
| [1] 曹怀远. 麻黄素中毒致尿潴留2例报告[J]. 陕西新医药,1982,11(8):27. [2] 范先伟. 口服麻黄碱引起尿潴留3例[J].实用医学杂志,1989,5(1):49. [3] 张桂林,王一琳. 口服麻黄素及百喘朋致老年人尿潴留2例[J]. 中国民政医学杂志,1996,8(4):244. [4] 马艳秋. 麻黄碱过量致尿潴留1例的护理[J]. 齐鲁护理杂志,2001,7(9):649. [5] 朱摇玲,汪民海. 复方盐酸伪麻黄碱缓释胶囊致排尿困难2例[J]. 安徽医药,2011,15(5):628. [6] 国家药典委员会. 中华人民共和国药典:一部(2015年版)[S]. 北京:中国医药科技出版社,2015:320-321. [7] 余光青,冷伟. 浅谈麻黄在小儿遗尿症中的应用[J]. 现代中医药,2018,38(5):109-111. [8] 林祥启. 麻黄汤治疗小儿遗尿症 56 例[J].实用中医药杂志,2000,16(1):24-25. [9] 彭宪章. 用麻杏石甘汤加味治愈遗尿症[J].新医药学杂志,1977,(11):31-32. [10] 吴力群. 刘弼臣教授临床应用麻杏石甘汤的经验[J].中国中西医结合儿科学,2010,2(1):56-58. [11] 陈芳瑜. 麻黄治疗遗尿症 331例临床分析[J].海峡药学,2004,16(1):88-89. [12] 李国芳. 俞景茂教授治疗小儿遗尿症经验介绍[J].中医儿科杂志,2016,12(4):12-15. [13] 宋艳红,宋晓辉,郭玉香. 麻黄素与654-2治疗小儿神经性尿频54例[J]. 黑龙江医学,1998,22(6):32. [14] 国家药典委员会. 临床用药须知:中药饮片卷(2015年版)[S]. 北京:中国医药科技出版社,2017:77. [15] 阿部靖之著,郭恒岳摘译. 麻黄提取物对家兔尿道及膀胱平滑肌的影响以及对腹压性尿失禁的作用[J]. 国外医学中医中药分册,2005,27(3):173-174. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
